Company Monitoring Page for Astellas

latest headlines for company on cafepharma

When Japanese Pharma Report, These American Biotechs React
Motley Fool
Sat, 11/2/13 - 11:22 am
Tags:
Arena Pharmaceuticals, Medivation, JNJ, Vivus, Astellas, Eisai
Medivation, Astellas prostate cancer drug meets trial goals
Yahoo/Reuters
Tue, 10/22/13 - 08:07 am
Tags:
Medivation, prostate cancer, Astellas, Enzalutamide
Top 15 Drug Launch Superstars
Fierce Pharma
Thu, 10/3/13 - 10:35 am
Tags:
drug launches, Eylea, Regeneron, Bayer, Tecfidera, Biogen Idec, Kalydeco, Vertex Pharmaceuticals, Kadcyla, Roche, Genentech, Victoza, Novo Nordisk, Gilenya, Novartis, Zytiga, JNJ, Yervoy, Bristol-Myers Squibb, Stribild, Gilead Sciences Xtandi, Medivation, Astellas, Afinitor, Amgen, Prolia, Stelara, Kyprolis, Xarelto, ONYX Pharmaceuticals
Top-line Data on Astellas' Isavuconazole
Yahoo/Zacks
Tue, 10/1/13 - 06:03 pm
Tags:
Astellas, isavuconazole, antifungals
Can Xtandi Become the Go-To Prostate Drug?
Motley Fool
Sat, 09/21/13 - 10:29 am
Tags:
Xtandi, prostate cancer, Medivation, Astellas
These biotech names are ripe for takeover: Cramer
CNBC
Wed, 08/28/13 - 09:50 am
Tags:
M&A, Amgen, ONYX Pharmaceuticals, Medivation, Astellas, Seattle Genetics
Astellas Launches Xtandi in the UK
Yahoo/Zacks
Sat, 07/13/13 - 11:42 am
Tags:
Astellas, Xtandi, prostate cancer
Astellas/Vical Start TransVax Phase III Study
Yahoo/Zacks
Fri, 06/28/13 - 10:30 am
Tags:
CMV, cytomegalovirus, TransVax, clinical trials, Astellas, vaccines, Vical
Seattle Genetics, Astellas affiliate announce co-development of added ADC
The Fly on the Wall
Thu, 06/27/13 - 10:37 am
Tags:
Seattle Genetics, antibody-drug conjugate, Astellas, ASG-15ME, Agensys, bladder cancer, lung cancer
Medivation and Astellas Initiate Phase 2 Study of Enzalutamide in Breast Cancer Patients
Yahoo
Wed, 06/26/13 - 10:44 am
Tags:
Medivation, Astellas, Enzalutamide, breast cancer
Cytokinetics-Astellas Agree to Develop Muscle Treatments
Bloomberg
Tue, 06/25/13 - 12:22 pm
Tags:
Astellas, Cytokinetics, muscle weakness, CK-2127107
Astellas' Xtandi approved in EU for prostate cancer
Pharma Times, UK
Mon, 06/24/13 - 10:50 am
Tags:
Astellas, Xtandi, prostate cancer, Europe, Medivation
Japan's Astellas looks to sell dermatology assets - sources
Reuters
Wed, 06/19/13 - 11:16 am
Tags:
Japan, dermatology, Astellas, M&A
Orphan Drug Status for Astellas' Candidate
Yahoo/Zacks
Fri, 05/31/13 - 09:36 am
Tags:
orphan drugs, Astellas, invasive aspergillosis, isavuconazole
Amgen to make move into Japan, takes on Astellas as partner
Yahoo/Reuters
Wed, 05/29/13 - 08:21 am
Tags:
Japan, Amgen, Astellas
This Week in Biotech
Motley Fool
Sun, 05/26/13 - 11:18 am
Tags:
AcelRx, Peregrine Pharmaceuticals, Merck, XenoPort, Aveo Pharmaceuticals, Astellas
Astellas and Medivation Announce Submission of Application for Marketing Approval of Enzalutamide, an Oral Androgen Receptor Inhibitor, in Japan
Yahoo/BusinessWire
Fri, 05/24/13 - 10:37 am
Tags:
Astellas, Medivation, Enzalutamide, prostate
A Few Hundred More Pharma Jobs Are Being Cut
Pharmalot
Wed, 05/15/13 - 10:43 am
Tags:
layoffs, Purdue Pharma, Astellas, OSI Pharmaceuticals, Intermezzo, contract reps
AstraZeneca, Cubist, Astellas Said to Make Bids for Optimer
Bloomberg
Tue, 05/14/13 - 08:32 am
Tags:
Cubist Pharmaceuticals, Optimer, M&A, AstraZeneca, Astellas
Astellas forecasts big sales growth as prostate drug catches hold
Fierce Pharma
Mon, 05/13/13 - 12:27 pm
Tags:
Astellas, Xtandi, Daiichi Sankyo, Japan, Takeda, prostate cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.